Archive for February, 2017

  • aside

    ISOFOL ANSÖKER OM VIKTIGT PATENT I USA

    Isofol Medical AB (publ) meddelar att en ny patentansökan lämnats in, den 14 februari, 2017, till det amerikanska patentverket (US…

    by
  • aside

    ISOFOL FILES IMPORTANT NEW US PATENT APPLICATION

    Isofol Medical AB (publ) today announces that a new patent application was filed, on February 14, 2017, to the US…

    by
  • aside

    EXTRA BOLAGSSTÄMMA I ISOFOL MEDICAL AB

    Aktieägarna i Isofol Medical AB (publ) kallas härmed till extra bolagsstämma onsdagen den 22 februari 2017 klockan 17.00 i Isofols…

    by
  • aside

    SCRIP INTELLIGENCE, A LEADING SOURCE OF NEWS AND STRATEGIC ANALYSIS FOR THE GLOBAL PHARMACEUTICAL INDUSTRY, PUBLISH ARTICLE ABOUT ISOFOL MEDICAL AB’S LEAD CANDIDATE MODUFOLIN®, AND THE UPCOMING PIVOTAL PHASE III STUDY IN METASTATIC COLORECTAL CANCER

    John Davis, journalist and editor for more than 30 years, of Scrip Intelligence recently interviewed Anders Rabbe, CEO of Isofol…

    by